Warberg Asset Management’s Core Scientific Tranche 1 Warrants CORZW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.55M Sell
383,028
-2,000
-0.5% -$25.9K 0.47% 34
2026
Q2
$7.24M Buy
385,028
+117,128
+44% +$1.97M 1.31% 13
2026
Q1
$2.34M Buy
267,900
+46,000
+21% +$493K 0.39% 29
2025
Q4
$1.88M Buy
221,900
+29,350
+15% +$326K 0.23% 39
2025
Q3
$2.24M Sell
192,550
-1,964
-1% -$16.7K 0.36% 41
2025
Q2
$2.11M Sell
194,514
-17,309
-8% -$86.1K 0.33% 40
2025
Q1
$642K Sell
211,823
-104,474
-33% -$640K 0.11% 79
2024
Q4
$2.6M Buy
316,297
+23,700
+8% +$214K 0.4% 37
2024
Q3
$1.97M Buy
292,597
+25,866
+10% +$143K 0.35% 46
2024
Q2
$1.2M Buy
+266,731
New +$542K 0.18% 50

Other funds holding CORZW

Warberg Asset Management's CORZW Position: Q3 2026 in Review

Warberg Asset Management reduced its Core Scientific Tranche 1 Warrants (CORZW) stake by 0.52% in Q3 2026, selling an estimated $25.9K and leaving 383,028 shares worth $3.55M. The position accounts for 0.47% of the portfolio, ranked #34.

Warberg Asset Management first reported a position in CORZW in Q2 2024 and has held it in 10 quarters since. The position peaked at $7.24M in Q2 2026. 56 funds tracked by Wall St. Rank hold CORZW as of Q3 2026.

  • Warberg Asset Management held 383,028 shares of Core Scientific Tranche 1 Warrants worth $3.55M as of Q3 2026.
  • Warberg Asset Management sold 2,000 Core Scientific Tranche 1 Warrants shares in Q3 2026, an estimated $25.9K.
  • Core Scientific Tranche 1 Warrants made up 0.47% of Warberg Asset Management's portfolio in Q3 2026, its #34 holding.
  • Warberg Asset Management first reported a position in Core Scientific Tranche 1 Warrants in Q2 2024 and has held it in 10 quarters since.
  • Warberg Asset Management's Core Scientific Tranche 1 Warrants position peaked at $7.24M in Q2 2026.
  • 56 funds tracked by Wall St. Rank held Core Scientific Tranche 1 Warrants as of Q3 2026.

Based on Warberg Asset Management's 13F filing for Q3 2026, filed 2 Nov 2026.